Amandeep Singh, Deepa Negi, Simranjeet Kaur, Sankha Bhattachary* and Gurmeet Singh Pages 342 - 357 ( 16 )
Cancer is a pivotal disease, which is a serious concern towards scientific research. In the recent era of scientific discovery and innovation, probiotics have been proposed as a new preventive and therapeutic option in therapy and to control cancer growth. Probiotics may thus offer a new way in research to investigate active compounds in different probiotic strains having anticancer features. Studies in laboratory animals and cell lines with respect to cancer treatments are encouraging. With rare conventional treatments, the need for new alternatives as the transportation of chemotherapeutic agents by nanocarriers using nanotechnology is one such approach. This review considers various drug delivery systems used in the therapy of cervical cancer, such as dendrimers, liposomes and nanoparticles. These drug delivery systems assist in the improvement of pharmacological activity, solubility, bioavailability and, thus, facilitating new innovative therapeutic technologies. This review summarizes the application of nanotechnology and probiotics in the treatment of cervical cancer.
Carcinoma, cervical cancer, liposomes, nanocarrier, novel drug delivery system, probiotics.
Department of Pharmaceutics, ISF College of Pharmacy, Moga-142001, Punjab, Department of Pharmaceutics, ISF College of Pharmacy, Moga-142001, Punjab, Faculty of Pharmaceutical Sciences, PCTE Group of Institutes, Baddowal- 141012, Ludhiana, Punjab, Department of Pharmaceutics, ISF College of Pharmacy, Moga-142001, Punjab, Department of Pharmaceutics, ISF College of Pharmacy, Moga-142001, Punjab